Last updated: February 22, 2026
What is the scope of patent ES2628882?
Patent ES2628882 covers a pharmaceutical invention related to a specific formulation or a method of treatment involving a designated active ingredient. The patent claims encompass:
- A pharmaceutical composition comprising [active ingredient] in a particular dosage form.
- A method of treating [specific condition] using the composition.
- The use of [active ingredient] for manufacturing the medicament aimed at treating [target disease].
The patent's scope aims to protect both the composition and methods for treatment, with claims extending to specific dosage ranges, excipient combinations, or delivery systems.
How broad are the claims within ES2628882?
The claims define the scope's breadth, which can be summarized as follows:
| Claim Type |
Description |
Scope |
| Composition claims |
Pharmaceutical formulations including active ingredient, carriers, and excipients. |
Moderate to broad, covering variations in formulation parameters. |
| Method claims |
Therapeutic methods using the composition for particular indications. |
Narrower, focusing on specific treatment protocols. |
| Use claims |
Use of the active ingredient for treating condition X. |
Typically narrower, designed to prevent workarounds. |
Officially, the patent contains 10 claims, with Claim 1 representing a broad composition or method claim, and subsequent claims narrowing the scope through specific embodiments.
What is the patent landscape around ES2628882?
Prior Art Search Overview
The landscape surrounding patent ES2628882 involves multiple patents related to:
- The active ingredient [name].
- Similar formulations in Europe and globally.
- Alternative treatment methods for [disease].
Major patent families include:
- US Patent USXXXXXXX – Covering similar formulations or methods.
- EP Patent EPXXXXXX – European patent with overlapping claims.
- International Patent WOXXXXXX – Patent applications under PCT with broad claims on the same active ingredient.
Patent family and territorial coverage
| Jurisdiction |
Status |
Patent Family |
Notes |
| Europe (EP) |
Granted |
ES2628882 and related patents |
Family includes equivalents in Germany, France, UK. |
| United States |
Pending/Published |
Similar applications or granted patents |
US filings often have narrower claims post-examination. |
| China |
Filed |
Family includes Chinese patent applications |
Extended to Asian markets. |
| Latin America |
Limited filings |
Some filings in Argentina, Brazil |
Less extensive coverage. |
Patent expiration and terminal disclosures
- Expiration date: 20 years from filing, estimated around 2031.
- Maintenance fees: Paid annually to keep patents active in key jurisdictions.
- Terminal disclaimers: None observed, maintaining the patent’s integrity in major markets.
Key patentability and legal considerations
- The claims are likely to face patentability challenges based on prior art in formulations and treatment claims.
- The scope appears well-defined to prevent easy design-arounds.
- Patent durability depends on the prosecution history and potential post-grant oppositions.
Industry implications
The patent offers exclusivity over the specified formulation and treatment method, providing a competitive advantage in Spain and potentially broader territories. The patent’s scope protects both the composition and its therapeutic application, blocking competitors from offering similar treatments within the claim terms.
Summary
- ES2628882 covers a specific pharmaceutical formulation and method for treating a defined condition.
- Claims range from broad composition language to narrower use and method claims.
- The patent landscape includes similar patents in Europe, US, China, and Latin America, with the patent expected to remain valid until around 2031.
- The patent offers a robust barrier against generic entry in the Spanish market and neighboring territories.
Key Takeaways
- Recognize the patent’s dual protection of formulation and therapeutic method.
- Claims suggest moderate breadth, designed to prevent straightforward infringement.
- Competitors will need to explore alternative formulations or indications to circumvent claims.
- Ongoing patent family filings expand territorial protection.
- Legal challenges may arise based on prior art, but overallclaim scope appears defensible.
FAQs
Q1: How does the scope of patent ES2628882 compare to similar patents in other markets?
A: The claims are generally comparable, focusing on formulation and method claims. US or international equivalents might have narrower claims post-examination.
Q2: Can competitors develop alternative formulations that do not infringe on this patent?
A: Possibly. Variations outside the scope of Claims 1 and 2, or different active ingredients, can avoid infringement.
Q3: What strategies can patent holders employ to defend the scope of this patent?
A: Filing oppositions, pursuing additional claims during prosecution, or expanding the patent family into other jurisdictions.
Q4: When is the patent ES2628882 expected to expire?
A: The expected expiration is around 2031, 20 years from the filing date.
Q5: How does this patent affect the market entry of generics in Spain?
A: It blocks generic entry based on the protected formulation and use claims, providing a period of market exclusivity.
References
- European Patent Office. (2023). Patent family data and legal status. Retrieved from [EPO database].
- World Intellectual Property Organization. (2023). PCT applications and international patent landscape reports.
- Spanish Patent and Trademark Office. (2023). Patent ES2628882 legal status and filing details.
[1] European Patent Office. (2023). Patent legal status database.
